Context Therapeutics Stock Overlap Studies Double Exponential Moving Average
| CNTX Stock | USD 1.36 0.03 2.16% |
| Symbol |
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to Context Therapeutics changes than the simple moving average.
Context Therapeutics Technical Analysis Modules
Most technical analysis of Context Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Context from various momentum indicators to cycle indicators. When you analyze Context charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Context Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Context Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Context Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Context Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Context Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Context Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Context Therapeutics, we also check how macroeconomic factors affect Context Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2022 | 2023 | 2024 (projected) | Current Ratio | 11.8 | 3.83 | 5.21 | Net Debt To EBITDA | 2.39 | 0.58 | 0.55 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Context Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Align your values with your investing style
In addition to having Context Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 40 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | FinTech Invested over 40 shares | |
 | Macroaxis Picks Invested few shares | |
 | Impulse Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Millennials Best Invested few shares | |
 | Technology Invested few shares | |
 | Investing Invested few shares | |
Additional Tools for Context Stock Analysis
When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.